Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

Becton, Dickinson and Company’s revenue for fiscal 2025 (year ended September 2025) was $21.8 billion, up 8.24% from fiscal 2024.

Revenue
−9.55%
EPS
−31.5%
Free cash flow
−31.6%
Total debt
−22.9%

Quarter to June 2026, against a year earlier

212.96 3.77 +1.80%
Market cap
$58.2B
P/E
64.1×
Fwd P/E
39.2×
Dividend yield
1.87%
F-score
7/9
Altman Z
1.85
Beneish M
−2.64
Dividend safety
67/100

Becton, Dickinson and Company (BDX) Shares outstanding

Alert me on Shares outstanding

Becton, Dickinson and Company's shares outstanding at the end of fiscal 2025 was $288.5M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $275.2M. Over the past ten years it has ranged from $207.5M (fiscal 2015) to $292.1M (fiscal 2021); the current reading is higher than 82% of that period. Becton, Dickinson and Company ranks 8th of 47 Medical Instruments & Supplies companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $288.5M (0.86%)
FY2024 $291.0M 0.91%
FY2023 $288.4M 0.36%
FY2022 $287.4M (1.62%)
FY2021 $292.1M 3.43%
FY2020 $282.4M 2.78%
FY2019 $274.8M 3.84%
FY2018 $264.6M 18.35%
FY2017 $223.6M 2.78%
FY2016 $217.5M 4.83%

Quarterly newest first

Period Shares outstanding Change
Jun 2026 $275.2M (1.95%)
Mar 2026 $280.6M (1.82%)
Dec 2025 $285.8M (0.92%)
Sep 2025 $288.5M 0.45%
42 more quarters

Against its own ten years

Low $207.5M High $292.1M
Ten-year median $282.4M
Current reading's percentile 82

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on BDX